Compare VVR & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VVR | ANGO |
|---|---|---|
| Founded | N/A | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 464.9M | 420.2M |
| IPO Year | 1998 | 2004 |
| Metric | VVR | ANGO |
|---|---|---|
| Price | $2.97 | $14.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 690.8K | 534.4K |
| Earning Date | 01-01-0001 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.51 |
| Revenue Next Year | N/A | $4.96 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $2.93 | $8.36 |
| 52 Week High | $3.78 | $15.20 |
| Indicator | VVR | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 50.80 | 65.35 |
| Support Level | $2.95 | $10.11 |
| Resistance Level | $3.02 | $15.20 |
| Average True Range (ATR) | 0.03 | 0.72 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 58.33 | 82.50 |
Invesco Senior Income Trust is a diversified, closed-end management investment company. The investment objective is to provide a high level of current income, consistent with preservation of capital. The Trust seeks to achieve its objectives by investing in a portfolio of interests in floating or variable senior loans to corporations, partnerships, and other entities which operate in a variety of industries and geographic regions. The Trust borrows money for investment purposes, which may create the opportunity for enhanced return, but also should be considered a speculative technique and may increase the Trust's volatility.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.